Crossmark

Illness management and recovery: one-year follow-up of a randomized controlled trial in Danish community mental health centers: long-term effects on clinical and personal recovery

Crossref DOI link: https://doi.org/10.1186/s12888-019-2048-0

Published Online: 2019-02-11

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jensen, Sofie Bratberg http://orcid.org/0000-0002-2517-5865
Dalum, Helle Stentoft

Korsbek, Lisa

Hjorthøj, Carsten

Mikkelsen, John Hagel

Thomsen, Karin

Kistrup, Kristen

Olander, Mette

Lindschou, Jane

Mueser, Kim T.

Nordentoft, Merete

Eplov, Lene Falgaard
Funding

Funding for this research was provided by:

TrygFonden (ID-nr. 103226)
License Information

Text and Data Mining valid from 2019-02-11
More Information

Article History

Received: 16 April 2018

Accepted: 31 January 2019

First Online: 11 February 2019

Ethics approval and consent to participate

: The trial was approved by the Ethics Committee in the Capital Region of Denmark (H-1-2010-134), reported to the Danish Data Protection Agency (RHP-2011-09), and registered on ExternalRef removed (NCT01361698) before recruitment began.The trial followed the international ethical guidelines for informed consent in clinical trials. Consent was voluntary, informed, and given both verbally and in writing. The participants did not receive a fee for their participation.

: Not applicable.

: The sponsors played no role in the study design, data collection, data analysis, data interpretation, or writing of the report. Except for Professor Kim Mueser, all authors declare that they have no conflicts of interests. Professor Kim Mueser declares that he was one of the original developers of the IMR program but holds no financial interest in its use.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below